138661-02-6

Basic information

• Product Name: Pentetreotide
• Synonyms: Pentetreotide;CA index name: L-Cysteinamide, N-[2-[[2-bis(carboxymethyl)amino]-ethyl](carboxymethyl)amino]ethyl]-N-(carboxymethyl)glycyl-;DTPA-octreotide;DTPA-SMS;L-Cysteinamide, N-[2-[[2-bis(carboxymethyl)amino]-ethyl](carboxymethyl)amino]ethyl]-N-(carboxymethyl)glycyl- D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl- L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (3-8)-disulfide;Pentreotide;[DTPA-D-Phe1]octreotide;N-[2-[[2-[Bis(carboxymethyl)amino]ethyl](carboxymethyl)amino]ethyl]-N-(carboxymethyl)-Gly-D-Phe-L-Cys(1)-L-Phe-D-Trp-L-Lys-L-Thr-L-Cys(1)-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-NH2
• CAS NO: 138661-02-6
• Molecular Formula: C62H85N13O19S2
• Molecular Weight: 1380.56
• Mol File: 138661-02-6.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 1717.4°Cat760mmHg
• Flash Point: 992.4°C
• Appearance: /
• Density: 1.47
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.678
• PKA: 1.67±0.10(Predicted)
• CAS DataBase Reference: Pentetreotide(CAS DataBase Reference)
• NIST Chemistry Reference: Pentetreotide(138661-02-6)
• EPA Substance Registry System: Pentetreotide(138661-02-6)

Safety Data

• Hazardous Substances Data: 138661-02-6(Hazardous Substances Data)

Usage

Chemical Properties

Colourless to off-white lyophilised solid

Brand name

Monodral Bromide (Sterling Winthrop).

InChI:InChI=1/C63H87N13O19S2/c1-37(78)48(34-77)70-62(94)50-36-97-96-35-49(71-58(90)45(25-39-13-5-3-6-14-39)66-51(80)29-75(31-53(83)84)23-21-74(30-52(81)82)22-24-76(32-54(85)86)33-55(87)88)61(93)68-46(26-40-15-7-4-8-16-40)59(91)69-47(27-41-28-65-43-18-10-9-17-42(41)43)60(92)67-44(19-11-12-20-64)57(89)73-56(38(2)79)63(95)72-50/h3-10,13-18,28,37-38,44-50,56,65,77-79H,11-12,19-27,29-36,64H2,1-2H3,(H,66,80)(H,67,92)(H,68,93)(H,69,91)(H,70,94)(H,71,90)(H,72,95)(H,73,89)(H,81,82)(H,83,84)(H,85,86)(H,87,88)/t37-,38-,44+,45-,46+,47-,48-,49+,50+,56+/m1/s1

Upstream product

• 1026637-64-8 C₆₃H₈₉N₁₃O₁₉S₂ 

Related news

Sarcoidosis mimicking metastatic carinoid on indium-111 Pentetreotide (cas 138661-02-6) scintigraphy09/09/2019

Carcinoid is a neuroendocrine neoplasm derived from primitive stem cells, occurring most frequently in the alimentary tract. Somatostatin-receptor scintigraphy with indium-111 pentetreotide is a sensitive and noninvasive technique for imaging carcinoid and its metastatic spread. However, nontumo...detailed

Original investigationIncremental Value of 111-In Pentetreotide (cas 138661-02-6) SPECT/CT Fusion Imaging of Neuroendocrine Tumors09/07/2019

Rationale and ObjectivesHybrid single photon-emission computed tomographic (SPECT) and computed tomographic (CT) imaging for the investigation of neuroendocrine tumors allows the fusion of functional and anatomic information in a rapid and efficient method. The aim of this study was to assess th...detailed

Molecular Imaging and Nuclear MedicineLateral ectopic thyroid mimics carotid body tumor on Indium-111 Pentetreotide (cas 138661-02-6) scintigraphy09/04/2019

A 34-year old woman with past history of anxiety, depression, and hypothyroidism resulting from prior total thyroidectomy for multinodular goiter presented with complaints of palpitations, sweating, and tachycardia. Clinical examination revealed a painless right lateral neck mass. USG/CT of the ...detailed

Relevant articles and documents

Concise site-specific synthesis of DTPA-peptide conjugates: Application to imaging probes for the chemokine receptor CXCR4

Diethylenetriaminepentaacetic acid (DTPA) is a useful chelating agent for radionuclides such as 68Ga, 99mTc and 111In, which are applicable to nuclear medicine imaging. In this study, we established a facile synthetic prot